- Oops!Something went wrong.Please try again later.
Shares of Health Catalyst (NASDAQ:HCAT) fell 8.31% in after-market trading after the company reported Q2 results.
Earnings per share rose 28.57% over the past year to ($0.15), which beat the estimate of ($0.22).
Revenue of $43,259,000 rose by 17.54% year over year, which beat the estimate of $42,140,000.
Earnings guidance hasn't been issued by the company for now.
The upcoming fiscal year's revenue expected to be between $177,200,000 and $181,200,000.
Conference Call Details
Date: Aug 11, 2020
Time: 05:00 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/mnfgfc9j
Company's 52-week high was at $49.85
Company's 52-week low was at $17.48
Price action over last quarter: Up 23.50%
Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.